Van Hulst, G., Jorssen, J., Jacobs, N., Henket, M., Louis, R., Schleich, F., Bureau, F., & Desmet, C. (2022). Anti-IL-5 mepolizumab minimally influences residual blood eosinophils in severe asthma. European Respiratory Journal. doi:10.1183/13993003.00935-2021 |
Van Hulst, G., Bureau, F., & Desmet, C. (2021). Eosinophils as Drivers of Severe Eosinophilic Asthma: Endotypes or Plasticity? International Journal of Molecular Sciences, 22 (18). doi:10.3390/ijms221810150 |
Van Hulst, G., Batugedara, H. M., Jorssen, J., Louis, R., Bureau, F., & Desmet, C. (2020). Eosinophil diversity in asthma. Biochemical Pharmacology, 179. doi:10.1016/j.bcp.2020.113963 |
Arnone, M., Van Hulst, G., Desmet, C., Bureau, F., Jacobs, N., Gerday, S. (Other coll.), HENKET, M. (Other coll.), & LOUIS, R. (Other coll.). (21 May 2019). Building a comprehensive map of immune cell populations in sputum from patients with eosinophilic asthma [Poster presentation]. EDT-Immunology day. |